Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 29, 2026 · Filed Oct 29, 2026
The CEO of Utah Medical Products paid $67K out of pocket for Utah Medical Products shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$66,750
Shares × reported transaction price
$25K–$100K
+0.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
7 days after results of Oct 22, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $66.80 on Oct 29, 2026, 24% above its 52-week low and 13% below its high, after a 10% drop over the previous 30 trading days
52-week range $53.80 (Nov 20, 2025) to $76.66 (Sep 22, 2026), 57% of the way up, from 250 adjusted closes. 30 trading days earlier: $74.19 on Sep 17, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any UTMD insider since Aug 2011. Kevin L Cornwell's largest purchase of UTMD in their filings since 2010. Kevin L Cornwell's first purchase of UTMD since Aug 2011
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.1% | −2.7% | +8.8% |
Past results only. Not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.